Cure My Disease

Don't miss your cure!

 Log in / Sign up

A tailored diet may lower heart risk in kidney failure

NCT ID NCT06377293

Disease control Sponsor: Far Eastern Memorial Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 31, 2026 · Last updated Sep 01, 2026 · Updated 1 time

Summary

This trial tests whether a specially designed 4-week diet can improve mineral balance and reduce cardiovascular risk in people with end-stage kidney disease on dialysis. The diet aims to correct common problems like high phosphate levels and inflammation. Researchers will compare changes in blood markers between those on the therapeutic diet and those on their usual diet. The study includes 50 adults who have been on dialysis for at least three months and can follow dietary instructions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A 4-week dialysis-specific therapeutic diet
What this could lead to
If successful, this diet could become a standard nutritional approach to reduce cardiovascular risk and improve overall health in dialysis patients.
What could go wrong
The trial is small (50 participants) and short (4 weeks), so results may not apply broadly. Dietary compliance is required, and the diet may not be palatable for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2025

Expected to finish

Jun 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subjects with aged older than 20 years * End-stage kidney disease (ESKD) undergoing maintenance dialysis for more than three months * Must have adequate dialysis * Good dietary compliance Exclusion Criteria: * Serum albumin level less than 2.5 g/dL * Hospitalization within the past 4 weeks * Prebiotics, probiotics, symbiotics or antibiotics use within the past 4 weeks * History of psychiatric disorders * Having mental retardation * Those who dislike of the study meals * Soft diet requirement * Vegetarian

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for End-stage kidney disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

End-stage kidney disease

Contacts and locations

Locations

  • Far Eastern Memorial Hospital

    New Taipei City, Banciao Dist., 220, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.